Moderna Stock: Bull vs. Bear

06:12am, Wednesday, 13'th Mar 2024
Many investors still see Moderna as a coronavirus stock and have questioned growth prospects. The main bull case for Moderna is that it's poised to return to growth soon.
Moderna, Inc. (MRNA) Barclays 26th Annual Global Healthcare Conference (Transcript)
Moderna (MRNA) concluded the recent trading session at $110.43, signifying a -1.38% move from its prior day's close.
Moderna (MRNA) surges amid initiation reports of a phase II/III study on Merck-partnered experimental cancer therapy to treat patients with cutaneous squamous cell carcinoma, a form of skin cancer.
Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Major U.S. equities indexes were mixed to open the trading week as stocks fluttered ahead of Tuesday's Consumer Price Inflation (CPI) report. After the previous CPI print revealed steeper-than-expecte
Moderna stock surged Monday, nearing its first breakout in over a year, after launching a third study of its cancer vaccine.
As an investor, you never really know how your investments will play out. Some companies that have been in long-term decline can suddenly become turnaround stocks and rise again, surprising everyone.
The global oncology ecosystem is at a pivotal juncture. Significant advancements in discovery, development, and delivery of novel cancer treatments are enhancing patient outcomes.
Healthcare stocks, especially biotech companies, are very risky for investors. Their share price can be highly volatile and surge higher or plummet lower based on news regarding a clinical trial, trea
ChatGPT stock predictions could be more than shots in the dark by AI. The processing and inferential power of artificial intelligence progresses seemingly exponentially every day.

Where Will Moderna Stock Be in 5 Years?

01:17pm, Sunday, 03'rd Mar 2024
Moderna's sales plunged in 2023 as demand for its COVID vaccine has been diminishing. The company has multiple products in its pipeline that could be key parts of its business in five years.

5 Top Stocks to Buy in March

05:45am, Sunday, 03'rd Mar 2024
Lululemon is showing no signs of slowing down. Moderna and Roku are poised for a comeback.

3 Reasons to Buy Moderna Stock

01:10pm, Saturday, 02'nd Mar 2024
Moderna is gaining on a rival in the coronavirus vaccine market. The biotech is nearing an important approval.

3 Magnificent Growth Stocks to Buy in March

09:30am, Saturday, 02'nd Mar 2024
Eli Lilly could have the world's future best-selling drug in its lineup. Moderna is poised to expand beyond COVID with several new products potentially on the way.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE